ASUA Inc. Logo

ASUA Inc.

Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.

246A | T

Overview

Corporate Details

ISIN(s):
JP3119640005
LEI:
Country:
Japan
Address:
名古屋市中村区黄金通一丁目11番地
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

ASUA Inc. is a specialized consulting and solutions provider focused on the logistics and transportation sectors. The company enhances operational safety, efficiency, and sustainability for logistics operators through its core business segments: Mobility Solutions and Network Solutions. The Mobility Solutions division provides logistics outsourcing services, data solutions leveraging IoT, and comprehensive driver safety programs. The Network Solutions division offers consulting and sales of telecommunications equipment. A central component of its service portfolio is the "TRYES Program," an integrated consulting and cloud platform designed to support safety activities, driver education, and overall business improvement within the transportation industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-04 08:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.3 KB
2025-10-01 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.1 KB
2025-09-26 09:01
Regulatory News Service
確認書
Japanese 8.1 KB
2025-09-26 09:00
Annual Report
有価証券報告書-第31期(2024/07/01-2025/06/30)
Japanese 2.3 MB
2025-09-04 08:01
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.8 KB
2025-02-13 08:01
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-02-13 08:00
Interim Report
半期報告書-第31期(2024/07/01-2025/06/30)
Japanese 151.7 KB
2024-09-30 08:31
Post-Annual General Meeting Information
臨時報告書
Japanese 20.1 KB
2024-09-30 08:25
Registration Form
確認書
Japanese 8.1 KB
2024-09-30 08:24
Annual Report
有価証券報告書-第30期(2023/07/01-2024/06/30)
Japanese 2.4 MB
2024-09-17 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB
2024-09-06 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.9 MB
2024-08-23 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 5.8 MB

Automate Your Workflow. Get a real-time feed of all ASUA Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASUA Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ASUA Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea 251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea 086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America BOLT
Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel BONS

Talk to a Data Expert

Have a question? We'll get back to you promptly.